This image is not available for purchase in your country.

Palbociclib breast cancer drug

Palbociclib breast cancer drug

C049/3590

Rights Managed

69.6 MB (10.9 MB compressed)

6048 x 4024 pixels

51.3 x 34.0 cm ⏐ 20.2 x 13.4 in (300dpi)

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY

Restrictions

Editorial use only.

Caption

Box of palbociclib breast cancer drug capsules. This drug, marketed as Ibrance, is a kinase inhibitor. It acts on cyclin-dependent kinases 4 and 6, which regulate the cell cycle. Blocking their action prevents cell division and the growth of the cancer.

Release details

Model release available. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Calculate price
  • Add to board